Episode 272: Journal Club | COVID-19 Retinal Detachment Presentation, Racial and Socioeconomic Disparities in Visual Impairment, Hormone Therapy Association with RVO, Ranibizumab Biosimilar
Manage episode 280788923 series 1302113
Drs. Nicolas Farber, Priya Vakharia, and Yoshihiro Yonekawa join for a journal club examining four publications in major ophthalmology journals.
Financial Disclosures: Dr. Sridhar is a consultant for Regeneron, Alcon, Dorc, and Oxurion. Dr. Yonekawa is a consultant for Alcon, Alimera, Allergan, and Genentech. Dr. Farber and Dr. Vakharia have no disclosures.
Retinal Detachment Presentation During COVID-19 Pandemic (https://www.aaojournal.org/article/S0161-6420(20)31006-X/fulltext)
Racial and Socioeconomic Disparities in Visual Impairment (https://www.aaojournal.org/article/S0161-6420(20)31044-7/fulltext)
Hormone Therapy Association with Retinal Vascular Occlusion (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2772809)
Ranibizumab Biosimilar Head-to-Head (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2772987)